HomeInsights52 Week Low Stocks

Medicamen Biotech Ltd 52 Week Low

Medicamen Biotech Ltd 52 Week Low

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Jan 2, 2025)

stocks purchased

3.0 K

Stocks Traded

(Jan 2, 2025)

Last Updated on: Jan 03, 2025

Image

Medicamen Biotech Ltd

NSE: MEDICAMEQ

YEARLOW

₹ 356.75

Last updated on: Jan 02, 2025

Key Highlights

  • The 52 Week Low of Medicamen Biotech Ltd is ₹ 356.75 as of 02 Jan 25 .

Company Fundamentals for Medicamen Biotech Ltd

No data available

Market Price of Medicamen Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Medicamen Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Jan 2025523.4
01 Jan 2025506.7
31 Dec 2024510.9
30 Dec 2024499.5
27 Dec 2024514.8
26 Dec 2024506.05
24 Dec 2024520
23 Dec 2024519
20 Dec 2024522.55
19 Dec 2024549.25

Asset Value vs Market Value of Medicamen Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Medicamen Biotech Ltd

No data available

* All values are in crore

Medicamen Biotech Ltd News Hub

News

Medicamen Biotech declare Quarterly Result

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 14 Novem...

Read more

08 Nov 2024 12:28

News

Medicamen Biotech to conduct AGM

Medicamen Biotech announced that the Annual General Meeting (AGM) of the company will be h...

Read more

13 Sep 2024 11:43

News

Medicamen Biotech to conduct board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 13 Augus...

Read more

12 Aug 2024 10:31

News

Board of Medicamen Biotech recommends Final Dividend

Medicamen Biotech announced that the Board of Directors of the Company at its meeting held...

Read more

29 May 2024 17:32

News

Medicamen Biotech schedules board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 29 May 2...

Read more

25 May 2024 15:28

News

Medicamen Biotech to conduct board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 12 Febru...

Read more

06 Feb 2024 14:01

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Medicamen Biotech Ltd

Why is it important to track the 52-week low of Medicamen Biotech Ltd stocks?

Investors should monitor the 52-week low of Medicamen Biotech Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Medicamen Biotech Ltd stocks hitting a 52-week low?

Factors leading to Medicamen Biotech Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Medicamen Biotech Ltd stocks when they hit a 52-week low?

Buying Medicamen Biotech Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Medicamen Biotech Ltd stocks?

Investors should monitor the 52-week low of Medicamen Biotech Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Medicamen Biotech Ltd stock at their 52-week low?

An investor can analyze the reasons for the Medicamen Biotech Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Medicamen Biotech Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Medicamen Biotech Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Medicamen Biotech Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions